Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
2.4M
-
Shares change
-
-98.2K
-
Total reported value, excl. options
-
$161M
-
Value change
-
-$6.99M
-
Number of buys
-
53
-
Number of sells
-
-50
-
Price
-
$66.81
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q2 2024
119 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q2 2024.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.4M shares
of 3.2M outstanding shares and own 74.98% of the company stock.
Largest 10 shareholders include FMR LLC (414K shares), RENAISSANCE TECHNOLOGIES LLC (227K shares), BlackRock Inc. (197K shares), VANGUARD GROUP INC (179K shares), DIMENSIONAL FUND ADVISORS LP (170K shares), BRANDES INVESTMENT PARTNERS, LP (117K shares), GEODE CAPITAL MANAGEMENT, LLC (88.6K shares), Ranger Investment Management, L.P. (84.8K shares), STATE STREET CORP (80.2K shares), and RICE HALL JAMES & ASSOCIATES, LLC (67K shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.